{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:39:41Z","timestamp":1793453981459,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s40263-012-0030-1","type":"journal-article","created":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T11:05:56Z","timestamp":1369652756000},"page":"21-27","source":"Crossref","is-referenced-by-count":17,"title":["Evidence for the Benefits of Nonantipsychotic Pharmacological Augmentation in the Treatment of Depression"],"prefix":"10.1007","volume":"27","author":[{"given":"Chia-Ming","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,28]]},"reference":[{"issue":"1","key":"30_CR1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","volume":"19","author":"GI Papakostas","year":"2009","unstructured":"Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol. 2009;19(1):34\u201340.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"30_CR2","first-page":"627","volume":"23","author":"AJ Rush","year":"2009","unstructured":"Rush AJ, et al. STAR*D: revising conventional wisdom. CNS Drugs. 2009;23(8):627\u201347.","journal-title":"CNS Drugs"},{"issue":"1","key":"30_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0033291709006011","volume":"40","author":"AA Nierenberg","year":"2010","unstructured":"Nierenberg AA, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med. 2010;40(1):41\u201350.","journal-title":"Psychol Med"},{"issue":"6","key":"30_CR4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1017\/S0033291700033146","volume":"25","author":"ES Paykel","year":"1995","unstructured":"Paykel ES, et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995;25(6):1171\u201380.","journal-title":"Psychol Med"},{"issue":"Suppl. 13","key":"30_CR5","first-page":"18","volume":"64","author":"ME Thase","year":"2003","unstructured":"Thase ME. Evaluating antidepressant therapies: remission as the optimal outcome. J Clin Psychiatry. 2003;64(Suppl. 13):18\u201325.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"30_CR6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/14656561003614781","volume":"11","author":"NS Philip","year":"2010","unstructured":"Philip NS, et al. Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era. Expert Opin Pharmacother. 2010;11(5):709\u201322.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"30_CR7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/11530280-000000000-00000","volume":"24","author":"RC Shelton","year":"2010","unstructured":"Shelton RC, et al. Therapeutic options for treatment-resistant depression. CNS Drugs. 2010;24(2):131\u201361.","journal-title":"CNS Drugs"},{"issue":"84","key":"30_CR8","first-page":"119","volume":"20","author":"R Zaratiegui","year":"2009","unstructured":"Zaratiegui R. STAR*D study: searching strategies regarding lack of response to an SSRI. Vertex. 2009;20(84):119\u201328.","journal-title":"Vertex"},{"issue":"1","key":"30_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/11587620-000000000-00000","volume":"71","author":"KR Connolly","year":"2011","unstructured":"Connolly KR, Thase ME. If at first you don\u2019t succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Drugs. 2011;71(1):43\u201364.","journal-title":"Drugs"},{"issue":"1","key":"30_CR10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/YCO.0b013e3283413505","volume":"24","author":"J Chen","year":"2011","unstructured":"Chen J, Gao K, Kemp DE. Second-generation antipsychotics in major depressive disorder: update and clinical perspective. Curr Opin Psychiatry. 2011;24(1):10\u20137.","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"30_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10401230209147450","volume":"14","author":"CM Dording","year":"2002","unstructured":"Dording CM, et al. The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists. Ann Clin Psychiatry. 2002;14(3):143\u20137.","journal-title":"Ann Clin Psychiatry"},{"issue":"5","key":"30_CR12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/070674370004500509","volume":"45","author":"D Mischoulon","year":"2000","unstructured":"Mischoulon D, et al. Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians. Can J Psychiatry. 2000;45(5):476\u201381.","journal-title":"Can J Psychiatry"},{"issue":"4 Suppl.","key":"30_CR13","first-page":"1","volume":"157","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157(4 Suppl.):1\u201345.","journal-title":"Am J Psychiatry"},{"issue":"Suppl. 1","key":"30_CR14","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jad.2009.06.041","volume":"117","author":"RW Lam","year":"2009","unstructured":"Lam RW, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord. 2009;117(Suppl. 1):S26\u201343.","journal-title":"J Affect Disord"},{"issue":"2","key":"30_CR15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15622970701227829","volume":"8","author":"M Bauer","year":"2007","unstructured":"Bauer M, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry. 2007;8(2):67\u2013104.","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"30_CR16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0447.2009.01492.x","volume":"121","author":"J Spijker","year":"2010","unstructured":"Spijker J, Nolen WA. An algorithm for the pharmacological treatment of depression. Acta Psychiatr Scand. 2010;121(3):180\u20139.","journal-title":"Acta Psychiatr Scand"},{"key":"30_CR17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1192\/bjp.138.3.252","volume":"138","author":"C Montigny De","year":"1981","unstructured":"De Montigny C, et al. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry. 1981;138:252\u20136.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"30_CR18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00004714-199910000-00006","volume":"19","author":"M Bauer","year":"1999","unstructured":"Bauer M, Dopfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol. 1999;19(5):427\u201334.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"30_CR19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4088\/JCP.v68n0617","volume":"68","author":"NA Crossley","year":"2007","unstructured":"Crossley NA, Bauer M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry. 2007;68(6):935\u201340.","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"30_CR20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archpsyc.1983.01790110077013","volume":"40","author":"GR Heninger","year":"1983","unstructured":"Heninger GR, Charney DS, Sternberg DE. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression. Arch Gen Psychiatry. 1983;40(12):1335\u201342.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"30_CR21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/070674378603100506","volume":"31","author":"D Kantor","year":"1986","unstructured":"Kantor D, et al. The benefit of lithium carbonate adjunct in refractory depression\u2014fact or fiction? Can J Psychiatry. 1986;31(5):416\u20138.","journal-title":"Can J Psychiatry"},{"issue":"2","key":"30_CR22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00004714-198804000-00007","volume":"8","author":"PM Zusky","year":"1988","unstructured":"Zusky PM, et al. Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. J Clin Psychopharmacol. 1988;8(2):120\u20134.","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"30_CR23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2007-1014603","volume":"22","author":"J Schopf","year":"1989","unstructured":"Schopf J, et al. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study. Pharmacopsychiatry. 1989;22(5):183\u20137.","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"30_CR24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00004850-199004000-00004","volume":"5","author":"M Browne","year":"1990","unstructured":"Browne M, et al. Lithium as an adjunct in the treatment of major depression. Int Clin Psychopharmacol. 1990;5(2):103\u201310.","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"30_CR25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archpsyc.1993.01820170065008","volume":"50","author":"RT Joffe","year":"1993","unstructured":"Joffe RT, et al. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry. 1993;50(5):387\u201393.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"30_CR26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1192\/bjp.166.1.80","volume":"166","author":"CL Katona","year":"1995","unstructured":"Katona CL, et al. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry. 1995;166(1):80\u20136.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"30_CR27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00004714-199608000-00006","volume":"16","author":"P Baumann","year":"1996","unstructured":"Baumann P, et al. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation. J Clin Psychopharmacol. 1996;16(4):307\u201314.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"30_CR28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000314308","volume":"62","author":"M Bauer","year":"2010","unstructured":"Bauer M, et al. Lithium\u2019s emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants. Neuropsychobiology. 2010;62(1):36\u201342.","journal-title":"Neuropsychobiology"},{"key":"30_CR29","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1192\/bjp.162.5.634","volume":"162","author":"G Stein","year":"1993","unstructured":"Stein G, Bernadt M. Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses. Br J Psychiatry. 1993;162:634\u201340.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"30_CR30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00004714-200302000-00013","volume":"23","author":"AA Nierenberg","year":"2003","unstructured":"Nierenberg AA, et al. Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants. J Clin Psychopharmacol. 2003;23(1):92\u20135.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"30_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0165-1781(90)90029-5","volume":"32","author":"RT Joffe","year":"1990","unstructured":"Joffe RT, Singer W. A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res. 1990;32(3):241\u201351.","journal-title":"Psychiatry Res"},{"issue":"9","key":"30_CR32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archpsyc.1996.01830090090013","volume":"53","author":"R Aronson","year":"1996","unstructured":"Aronson R, et al. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry. 1996;53(9):842\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"30_CR33","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1176\/appi.ajp.158.10.1617","volume":"158","author":"LL Altshuler","year":"2001","unstructured":"Altshuler LL, et al. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry. 2001;158(10):1617\u201322.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"30_CR34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S1461145707008206","volume":"11","author":"R Cooper-Kazaz","year":"2008","unstructured":"Cooper-Kazaz R, Lerer B. Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors. Int J Neuropsychopharmacol. 2008;11(5):685\u201399.","journal-title":"Int J Neuropsychopharmacol"},{"key":"30_CR35","doi-asserted-by":"crossref","unstructured":"Nierenberg AA, et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry. 2006;163(9):1519\u201330; quiz 1665.","DOI":"10.1176\/appi.ajp.163.9.1519"},{"issue":"9","key":"30_CR36","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4088\/JCP.v64n0911","volume":"64","author":"C DeBattista","year":"2003","unstructured":"DeBattista C, et al. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. J Clin Psychiatry. 2003;64(9):1057\u201364.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"30_CR37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4088\/JCP.v66n0112","volume":"66","author":"M Fava","year":"2005","unstructured":"Fava M, Thase ME, DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry. 2005;66(1):85\u201393.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"30_CR38","first-page":"217","volume":"52","author":"FM Jacobsen","year":"1991","unstructured":"Jacobsen FM. Possible augmentation of antidepressant response by buspirone. J Clin Psychiatry. 1991;52(5):217\u201320.","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"30_CR39","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","volume":"354","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243\u201352.","journal-title":"N Engl J Med"},{"issue":"12","key":"30_CR40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4088\/JCP.v59n1204","volume":"59","author":"M Landen","year":"1998","unstructured":"Landen M, et al. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression. J Clin Psychiatry. 1998;59(12):664\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"30_CR41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4088\/JCP.v62n0608","volume":"62","author":"BG Appelberg","year":"2001","unstructured":"Appelberg BG, et al. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. J Clin Psychiatry. 2001;62(6):448\u201352.","journal-title":"J Clin Psychiatry"},{"issue":"1\u20133","key":"30_CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0165-0327(02)00090-3","volume":"76","author":"E Onder","year":"2003","unstructured":"Onder E, Tural U. Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone. J Affect Disord. 2003;76(1\u20133):223\u20137.","journal-title":"J Affect Disord"},{"issue":"1\u20133","key":"30_CR43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0327(02)00404-4","volume":"79","author":"J Ballesteros","year":"2004","unstructured":"Ballesteros J, Callado LF. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. J Affect Disord. 2004;79(1\u20133):137\u201347.","journal-title":"J Affect Disord"},{"issue":"6","key":"30_CR44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.jcp.0000246212.03530.fd","volume":"26","author":"AA Patkar","year":"2006","unstructured":"Patkar AA, et al. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. J Clin Psychopharmacol. 2006;26(6):653\u20136.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"30_CR45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4088\/JCP.v69n0112","volume":"69","author":"AV Ravindran","year":"2008","unstructured":"Ravindran AV, et al. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry. 2008;69(1):87\u201394.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"30_CR46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/WNF.0b013e31817e559b","volume":"32","author":"CU Pae","year":"2009","unstructured":"Pae CU, et al. Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial. Clin Neuropharmacol. 2009;32(2):85\u20138.","journal-title":"Clin Neuropharmacol"},{"key":"30_CR47","doi-asserted-by":"crossref","unstructured":"Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry. 2011.","DOI":"10.1038\/mp.2011.100"},{"issue":"7","key":"30_CR48","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4088\/JCP.v68n0712","volume":"68","author":"PY Lin","year":"2007","unstructured":"Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7):1056\u201361.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 6","key":"30_CR49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4088\/JCP.8133su1c.03","volume":"70","author":"GI Papakostas","year":"2009","unstructured":"Papakostas GI. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry. 2009;70(Suppl. 6):16\u201325.","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"30_CR50","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4088\/JCP.10m06634","volume":"72","author":"ME Sublette","year":"2011","unstructured":"Sublette ME, et al. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry. 2011;72(12):1577\u201384.","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"30_CR51","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4088\/JCP.v65n0810","volume":"65","author":"GI Papakostas","year":"2004","unstructured":"Papakostas GI, et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder. Part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry. 2004;65(8):1090\u20135.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"30_CR52","first-page":"309","volume":"23","author":"M Alpert","year":"2003","unstructured":"Alpert M, Silva RR, Pouget ER. Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant. J Clin Psychopharmacol. 2003;23(3):309\u201313.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"30_CR53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ctcp.2010.01.003","volume":"16","author":"C Lazarou","year":"2010","unstructured":"Lazarou C, Kapsou M. The role of folic acid in prevention and treatment of depression: an overview of existing evidence and implications for practice. Complement Ther Clin Pract. 2010;16(3):161\u20136.","journal-title":"Complement Ther Clin Pract"},{"issue":"2","key":"30_CR54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-0327(00)00153-1","volume":"60","author":"A Coppen","year":"2000","unstructured":"Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord. 2000;60(2):121\u201330.","journal-title":"J Affect Disord"},{"issue":"8 Suppl.","key":"30_CR55","doi-asserted-by":"crossref","first-page":"2356S","DOI":"10.1093\/jn\/132.8.2356S","volume":"132","author":"NS Green","year":"2002","unstructured":"Green NS. Folic acid supplementation and prevention of birth defects. J Nutr. 2002;132(8 Suppl.):2356S\u201360S.","journal-title":"J Nutr"},{"issue":"3","key":"30_CR56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000091771","volume":"75","author":"M Fava","year":"2006","unstructured":"Fava M, Rush AJ. Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice. Psychother Psychosom. 2006;75(3):139\u201353.","journal-title":"Psychother Psychosom"},{"issue":"2","key":"30_CR57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/09638230903469269","volume":"19","author":"SP Thomas","year":"2010","unstructured":"Thomas SP, Nandhra HS, Jayaraman A. Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD). J Mental Health. 2010;19(2):168\u201375.","journal-title":"J Mental Health"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-012-0030-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-012-0030-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-012-0030-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T05:01:55Z","timestamp":1563080515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-012-0030-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":57,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1007\/s40263-012-0030-1","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}